Form 4 for VRSK Verisk Analytics
Accepted 2021-12-20 00:00:00 ET · period of report 2021-12-20 · accession 0001209191-21-070605 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-20 | 2021-12-20 | VRSK | Anquillare Mark V | COO, Group Pres | S - Sale+OE | $218.06 | -20.5K | 41.3K | -33% | -$4.47M |
| D | 2021-12-20 | 2021-12-20 | VRSK | Anquillare Mark V | COO, Group Pres | M - OptEx | $61.14 | +20.5K | 42.0K | +95% | +$1.25M |
| D | 2021-12-20 | 2021-12-20 | VRSK | Anquillare Mark V | COO, Group Pres | M - OptEx | $0.00 | -20.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-20 | S | D | 7,212 | $219.18 | 21,502 | D | — | — | (F5) These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $218.57 to $219.55, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (5). |
| 2 | Common | Common Stock | 2021-12-20 | S | D | 7,968 | $217.98 | 28,714 | D | — | — | (F4) These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $217.56 to $218.46, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (4). |
| 3 | Common | Common Stock | 2021-12-20 | S | D | 4,600 | $216.82 | 36,682 | D | — | — | (F3) These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $216.77 to $217.54, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (3). |
| 4 | Common | Common Stock | 2021-12-20 | S | D | 300 | $214.71 | 41,682 | D | — | — | (F1) These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $214.56 to $215.00, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1). |
| 5 | Common | Common Stock | 2021-12-20 | S | D | 400 | $216.02 | 41,282 | D | — | — | (F2) These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $215.80 to $216.43, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2). |
| 6 | Common | Common Stock | 2021-12-20 | M | A | 20,480 | $61.14 | 41,982 | D | — | — | |
| 7 | Derivative | Stock Option | 2021-12-20 | M | D | 20,480 | $0.00 | 0 | D | $61.14 · — to 2023-04-01 | 20,480 Common Stock | (F8) This stock option was granted under the Issuer's 2009 Equity Incentive Plan. (F9) Immediately. |